Bladder Cancer Academy (BCA) was created to ensure urology/oncology fellows, residents, and LUGPA physicians receive optimal education on bladder cancer diagnosis and management, advanced monitoring and care options, novel pharmaceutical therapies, and surgical advancements. BCA will convene the evening of Thursday, March 1, and continue through mid-day on Saturday, March 3, in St. Louis, Missouri.
This will be a unique opportunity for attendees to interact with the top thought leaders who play pivotal roles in advancing the treatment of bladder cancer. Our esteemed chairs have developed a comprehensive agenda addressing the most current and pressing topics in the field of bladder cancer that will include didactic lectures and case-based discussions.
This program is co-sponsored by MedReviews, LLC, publishers of Reviews in Urology® and LUGPA.